相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Schisandrin B protects against LPS-induced inflammatory lung injury by targeting MyD88
Weiwei Zhu et al.
PHYTOMEDICINE (2023)
Pharmacologic effects approach of essential oils and their components on respiratory diseases
Jia Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2023)
Essential oil of Acorus tatarinowii Schott inhibits neuroinflammation by suppressing NLRP3 inflammasome activation in 3 x Tg-AD transgenic mice
Zhiwei Xu et al.
PHYTOMEDICINE (2023)
Icariside II attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization
Lingling Deng et al.
JOURNAL OF ETHNOPHARMACOLOGY (2023)
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Benjamin J. Moss et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)
Idiopathic pulmonary fibrosis: Current and future treatment
Daniel S. Glass et al.
CLINICAL RESPIRATORY JOURNAL (2022)
Octacyclic and decacyclic ent-abietane dimers with cytotoxic activity from Euphorbia fischeriana steud
Yulin Peng et al.
CHINESE CHEMICAL LETTERS (2022)
Protective effect of Amomum Roxb. essential oils in lipopolysaccharide-induced acute lung injury mice and its metabolomics
Kai Zhao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation
Tian-qi Xuan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Jincheng Wang et al.
ACTA PHARMACEUTICA SINICA B (2022)
TGF-β in developmental and fibrogenic EMTs
Jun Ho Lee et al.
SEMINARS IN CANCER BIOLOGY (2022)
Risk factors for severe and critically ill COVID-19 patients: A review
Ya-dong Gao et al.
ALLERGY (2021)
Medicinal Inula Species: Phytochemistry, Biosynthesis, and Bioactivities
Cheng-Peng Sun et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2021)
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
James Patrick Finnerty et al.
BMC PULMONARY MEDICINE (2021)
Viral Respiratory Pathogens and Lung Injury
Nicola Clementi et al.
CLINICAL MICROBIOLOGY REVIEWS (2021)
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
Juergen Behr et al.
LANCET RESPIRATORY MEDICINE (2021)
A review of the botany, traditional uses, phytochemistry, and pharmacology of the Flos Inulae
Liu Yang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Over a century since ephedrine discovery: an updated revisit to its pharmacological aspects, functionality and toxicity in comparison to its herbal extracts
Mohamed Z. Gad et al.
FOOD & FUNCTION (2021)
Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease
Saleela M. Ruwanpura et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency
Haiyun Chen et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Inula japonica ameliorated bleomycin-induced pulmonary fibrosis via inhibiting soluble epoxide hydrolase
Wen-Yu Zhao et al.
BIOORGANIC CHEMISTRY (2020)
Mesenchymal stem cells reverse EMT process through blocking the activation of NF-κB and Hedgehog pathways in LPS-induced acute lung injury
Kun Xiao et al.
CELL DEATH & DISEASE (2020)
Role of Macrophages in Acute Lung Injury and Chronic Fibrosis Induced by Pulmonary Toxicants
Debra L. Laskin et al.
TOXICOLOGICAL SCIENCES (2019)
Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets
Justin C. Hewlett et al.
MATRIX BIOLOGY (2018)
Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD A Randomized Clinical Trial
Graham Devereux et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-β1 in A549, NCI-H441, and Calu-3 cells: Development of an in vitro model of respiratory epithelial cells in idiopathic pulmonary fibrosis
Kohei Togami et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)
Britanin attenuates ovalbumin-induced airway inflammation in a murine asthma model
Sun-Gun Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions
Veronica Della Latta et al.
PHARMACOLOGICAL RESEARCH (2015)
Aspiration-induced lung injury
Krishnan Raghavendran et al.
CRITICAL CARE MEDICINE (2011)